Not logged in
Share
Save
Share
SaveThe impact of immortal time bias on the estimated mortality benefit of antifibrotic therapy in IPF
Wilskow, Marit Bjorna; Diep, Phuong Phuong; Hyldgaard, Charlotte; Carlson, Lisa; Kalafatis, Dimitrios; Pesonen, Ida; Skoeld, Magnus; Shaker, Saher Burhan; Bendstrup, Elisabeth; Hoyer, Nils; Durheim, Michael Thomas
Share
Save
Share
Save
Share
SaveFibroblast activation protein and disease severity, progression, and survival in idiopathic pulmonary fibrosis
Prior, Thomas Skovhus; Hoyer, Nils; Davidsen, Jesper Romhild; Shaker, Saher Burhan; Hundahl, Malthe Pallesgaard; Lomholt, Soren; Deleuran, Bent Winding; Bendstrup, Elisabeth; Kragstrup, Tue Wenzel
Share
SaveVimentin serum biomarkers are differentially related to disease progression in idiopathic pulmonary fibrosis (IPF)
Simoes, Filipa B.; Hoyer, Nils; Prior, Thomas S.; Jessen, Henrik; Fredriksen, Peder; Karsdal, Morten; Leeming, Diana J.; Bendstrup, Elisabeth; Sand, Jannie M. B.; Shaker, Saher B.
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SaveAntibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases
Harboe, Zitta Barrella; Hamm, Sebastian Rask; Perez-Alos, Laura; Sivapalan, Pradeesh; Prieme, Helene; Wilcke, Torgny; Kjeldgaard, Peter; Shaker, Saher; Jordan, Alexander Svorre; Moller, Dina Leth; Heftdal, Line Dam; Madsen, Johannes Roth; Bayarri-Olmos, Rafael; Hansen, Cecilie Bo; Pries-Heje, Mia Marie; Hasselbalch, Rasmus Bo; Fogh, Kamille; Armenteros, Jose Juan Almagro; Hilsted, Linda; Sorensen, Erik; Lindegaard, Birgitte; Browatzki, Andrea; Biering-Sorensen, Tor; Frikke-Schmidt, Ruth; Ostrowski, Sisse Rye; Iversen, Kasper Karmark; Bundgaard, Henning; Nielsen, Susanne Dam; Garred, Peter; Jensen, Jens-Ulrik Staehr
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save